Daniel A. Heller: Overview

We are developing nanomedicines to target precision agents to disease sites, including to metastatic cancers. We are also addressing the problem of the early detection of cancer and other diseases by building implantable nanosensors. To enable the discovery of new medicines, we also inventing new nanosensors and imaging tools to accelerate drug development and biomedical research. Please check our recent publications and projects.